Flu News and Research

RSS

Elderly people at increased risk for getting flu

Flu season lurks around the corner throughout the United States, and gerontologists at the University of Alabama at Birmingham say the elderly are at increased risk for getting the flu and often have a worse time coping with flu symptoms than do younger people.

24 Oct 2013

New flu vaccine offers better protection against circulating flu viruses

Last year's flu season was considered one of the strongest and deadliest in recent decades, according to the CDC. In preparation for this year's flu season, Concentra, a subsidiary of Humana Inc., offers a flu vaccine to provide greater protection against circulating flu strains.

23 Oct 2013

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

The flu vaccine may not only ward off serious complications from influenza, it may also reduce the risk of heart attack or stroke by more than 50 per cent among those who have had a heart attack, according to new research led by Dr. Jacob Udell, a cardiologist at Women's College Hospital and clinician-scientist at the University of Toronto. What's more, the vaccine's heart protective effects may be even greater among those who receive a more potent vaccine.

23 Oct 2013

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Receiving an influenza vaccination was associated with a lower risk of major adverse cardiovascular events such as heart failure or hospitalization for heart attack, with the greatest treatment effect seen among patients with recent acute coronary syndrome (ACS; such as heart attack or unstable angina), according to a meta-analysis published in the October 23/30 issue of JAMA.

23 Oct 2013

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

A study led by St. Jude Children's Research Hospital scientists highlights a new approach for developing a universal influenza vaccine that could protect against multiple flu strains, including deadly pandemic strains. The research appears today in the advance online edition of the scientific journal Nature Immunology.

22 Oct 2013

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

NanoViricides, Inc. (the "Company") reports that its optimized injectable FluCide® drug candidate was found to be well tolerated in a non-GLP small animal safety/toxicology study. This study is an important step in the drug development pathway for FluCide.

21 Oct 2013

Whitehead Institute scientists discover insidious nature of influenza virus

Revealing influenza's truly insidious nature, Whitehead Institute scientists have discovered that the virus is able to infect its host by first killing off the cells of the immune system that are actually best equipped to neutralize the virus.

21 Oct 2013

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

The U.S. Food and Drug Administration today approved Opsumit (macitentan), a new drug to treat adults with pulmonary arterial hypertension (PAH), a chronic, progressive and debilitating disease that can lead to death or the need for lung transplantation.

19 Oct 2013

KidsLink enters into healthcare market

KidsLink, an online family management platform used to organize important documents, events, and milestones, announces its entry into the healthcare market in partnership with Piedmont Medical Center, a Tenet Healthcare hospital based in Rock Hill, South Carolina.

18 Oct 2013

Viewpoints: 'Surrender' by Republicans; 'myth' of income verification; 'this fight didn't end'

The health care reform law will not be defunded or delayed. No taxes will be cut, and the deal calls for no new cuts to federal spending or limits to social welfare programs. The only things Republicans achieved were billions of dollars in damage to the economy, harm to the nation's reputation and a rock-bottom public approval rating (10/16).

18 Oct 2013

Neutra working to help end staph infections in locker rooms

With football season now in full swing, a dangerous, highly resistant strain of staph infections is plaguing locker rooms across the country, potentially costing organizations such as the NFL and NCAA millions of dollars. Neutra Corp., a growing provider of all-natural wellness solutions, is working to help end the costly epidemic.

17 Oct 2013

State highlights: Calif. Gov. Vetoes 'biosimilars' bill; health data gateway opens in Calif.; L.A. health workers required to get flu shots

A selection of health policy stories from California. A bill that would have allowed "biosimilar" drugs to be substituted for biologic drugs was vetoed over the weekend by Gov. Jerry Brown (D), who said it was premature to pass the law until the Federal Drug Administration has worked out standards for the new drugs.

17 Oct 2013

First Edition: October 16, 2013

Today's headlines including stories detailing how certain health law provisions are factoring in to the continuing congressional budget stalemate.

16 Oct 2013

Shutdown commentaries: The man who championed the strategy; 'opening salvo in a generational war;' lack of funding hurts public health efforts

'I really believe we are in a great position right now," says Michael Needham, the 31-year-old president of Heritage Action, the lobbying arm of the nation's largest conservative think tank. By "we" he means the Republican Party and the conservative movement; their "great position" refers to the potential to win the political battle over the government shutdown. Though Texas Sen. Ted Cruz is the public face of the high-risk strategy to "defund" ObamaCare, the masterminds behind it are a new generation of young conservatives, chief among them Mr. Needham. From a tactical view, the strategy has been deployed with precision.

15 Oct 2013

Vivaldi Buys Flu Vaccine R&D Assets From Baxter

...

10 Oct 2013

FMCNA encourages dialysis patients to get vaccinated against flu

With early cases of seasonal flu already being reported in the U.S., Fresenius Medical Care North America (FMCNA), the nation's leading network of dialysis facilities, is strongly encouraging dialysis patients to get flu shots to protect themselves against this common infectious disease.

9 Oct 2013

Newly discovered compound could be developed as antifungal drug to treat fungal infections

On a molecular level, you have more in common with shower curtain mold or the mushrooms on your pizza than you might think. Humans and fungi share similar proteins, a biological bond that makes curing fungal infections difficult and expensive.

7 Oct 2013

Doctors prescribe antibiotics for sore throats and acute bronchitis, say researchers

A vast majority of people who see their doctors for sore throats or acute bronchitis receive antibiotics, yet only a small percentage should, according to analyses of two major national surveys being presented at IDWeek 2013-. Those illnesses usually are caused by viruses, and antibiotics - which only treat bacterial infections - do not help.

5 Oct 2013

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Researchers from the FEMSA Center of Biotechnology at Technologic of Monterrey (ITESM) designed a technology that uses grated carrot to obtain phenolic compounds that have a potential to prevent cancer, and cardiovascular and neurodegenerative diseases.

5 Oct 2013

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

A new way to attack flu viruses is taking shape in laboratories at Rutgers University, where scientists have identified chemical agents that block the virus's ability to replicate itself in cell culture.

4 Oct 2013

Flu News and Research

Elderly people at increased risk for getting flu

New flu vaccine offers better protection against circulating flu viruses

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Scientists highlight novel way to develop universal influenza vaccine that can protect against multiple flu strains

NanoViricides’ FluCide drug candidate found to be well tolerated in non-GLP safety/toxicology study

Whitehead Institute scientists discover insidious nature of influenza virus

Opsumit drug receives FDA approval to treat adults with pulmonary arterial hypertension

KidsLink enters into healthcare market

Viewpoints: 'Surrender' by Republicans; 'myth' of income verification; 'this fight didn't end'

Neutra working to help end staph infections in locker rooms

State highlights: Calif. Gov. Vetoes 'biosimilars' bill; health data gateway opens in Calif.; L.A. health workers required to get flu shots

First Edition: October 16, 2013

Shutdown commentaries: The man who championed the strategy; 'opening salvo in a generational war;' lack of funding hurts public health efforts

Vivaldi Buys Flu Vaccine R&D Assets From Baxter

FMCNA encourages dialysis patients to get vaccinated against flu

Newly discovered compound could be developed as antifungal drug to treat fungal infections

Doctors prescribe antibiotics for sore throats and acute bronchitis, say researchers

Bioactive compounds in carrot can be used as antiviral for treatment against flu

Scientists identify chemical agents that block flu virus's ability to replicate itself in cell culture

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News